Search Results - "Furue K"

Multiomics Reveals IL-17 Drives Epithelial Keratinization and Proliferation via EHF in Odontogenic Keratocysts.

Authors: Yi, Jing-Rui Zhong, Nian-Nian Liu, Xuan-Hao et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p4115. 19p.

Patients with congenital ichthyosis show differential activation of IL-23/Th17 pathway among various disease subtypes - A single-centre experience.

Authors: Kumar, Anoop Mahajan, Rahul Srivastava, Niharika et al.

Source: Indian Journal of Dermatology, Venereology & Leprology. May/Jun2026, Vol. 92 Issue 3, p1-9. 9p.

Immunomodulatory Effects of a Tick Salivary Serpin on Psoriasis-like Inflammation.

Authors: Jmel, Mohamed Amine Wu, Huimei Baaten, Constance C. F. M. J. et al.

Source: Life (2075-1729). Mar2026, Vol. 16 Issue 3, p427. 17p.

Ginsenoside Rg3 Ameliorates Psoriasis‐Like Dermatitis through Inhibition of NF‐κB/NLRP3 Inflammasome Signaling and Regulating Th17/Treg Balance.

Authors: Gao, Liyun Xie, Qingge Zhou, Zhaoli et al.

Source: Immunity, Inflammation & Disease. Feb2026, Vol. 14 Issue 2, p1-10. 10p.

IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in Psoriasis.

Authors: Svraka, Lejla Andersen, Anna Skarnvad Touborg, Toke et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1297. 14p.

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis.

Authors: Augustin, Matthias Armstrong, April Issa, Naiem T. et al.

Source: Dermatology & Therapy. Jan2026, Vol. 16 Issue 1, p277-291. 15p.

Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Authors: Campione, Elena Artosi, Fabio Shumak, Ruslana Gaeta et al.

Source: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1378. 18p.

Conjugation of Gold Nanoparticles to the Anti‐IL17A Aptamer Improves Anti‐Inflammatory Effects of the Aptamer in the Experimental Imiquimod‐Induced Psoriasis.

Authors: Khorrami, Razia Shobeiri, Saeideh Sadat Emami, Zahra et al.

Source: International Journal of Inflammation. 12/9/2025, Vol. 2025, p1-13. 13p.

Correlation between Interleukin-17A Gene Polymorphism and Psoriasis Disease Susceptibility and Severity: A Case–Control Study.

Authors: Maharana, Prateek Jena, Swapna Rattan, Roma et al.

Source: Clinical Dermatology Review. Oct-Dec2025, Vol. 9 Issue 4, p336-341. 6p.

This result is not displayed to guests.
Login for full access.

Extracellular ATP Contributes to Barrier Function and Inflammation in Atopic Dermatitis: Potential for Topical Treatment of Atopic Dermatitis by Targeting Extracellular ATP.

Authors: Yamamura, Kazuhiko Ohno, Fumitaka Yotsumoto, Shu et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12294. 11p.

Gut Dysbiosis and the Molecular Landscape of the Gut–Skin Axis: Comparative Insights and Therapeutic Implications for Atopic Dermatitis and Psoriasis.

Authors: Andrzejczak, Klara Kucharczyk, Emilia Sternak, Agata et al.

Source: Cells (2073-4409). Apr2026, Vol. 15 Issue 7, p594. 44p.

Review on TiO2 nanostructured photoanode and novel dyes for dye-sensitized solar cells application.

Authors: Yan, Yu Zhang, Yaofang Zhao, Yangfan et al.

Source: Journal of Materials Science; Mar2025, Vol. 60 Issue 11, p4975-5005, 31p

Personal approach for cancer treatment: A meta-analysis of Phase II clinical trials.

Authors: Potievskiy, Mikhail B. Zharova, Elena P. Nekrasova, Lidia A. et al.

Source: PLoS ONE. 9/26/2025, Vol. 20 Issue 9, p1-13. 13p.

Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis.

Authors: Cantó, Elisabet del Prado, María Elena Vilarrasa, Eva et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8118. 20p.

The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA).

Authors: Soung, Jennifer Laquer, Vivian Zirwas, Matthew et al.

Source: Dermatology & Therapy. Sep2025, Vol. 15 Issue 9, p2631-2644. 14p.

Benralizumab Depletes IL‐5Rα‐Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis.

Authors: Whetstone, Christiane E. Cusack, Ruth P. Price, Emma L. et al.

Source: Clinical & Translational Allergy. Aug2025, Vol. 15 Issue 8, p1-12. 12p.

Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer.

Authors: Li, Jinping Deng, Zhenyan Yan, Zhaofang et al.

Source: Scientific Reports. 7/28/2025, Vol. 15 Issue 1, p1-14. 14p.

Development of IL‐17A inhibitor‐induced atopic dermatitis‐like rash in psoriasis patients: Insights into immune shift.

Authors: Li, Qiuju Li, Xiuying Li, Wenyu et al.

Source: Experimental Dermatology. Jan2024, Vol. 33 Issue 1, p1-7. 7p.

Molecular landscape of acral melanoma: an integrative review.

Authors: Castillo, Jesús José André Quintana Silva, Wagner Barcelos, Denise et al.

Source: Surgical & Experimental Pathology. 6/20/2025, Vol. 8 Issue 1, p1-9. 9p.